Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model

Objectives. To explore the efficacy and the mechanism of the umbilical cord-derived cells combined with cyclosporine A (CsA) in treating aplastic anemia (AA) in mice. Methods. Immune-mediated AA model mice were treated with CsA + UC mesenchymal stem cells (UC-MSC), CsA + umbilical cord blood regulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Zesong Chen, Chen Yang, Jiang Ji, Miao Chen, Bing Han
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2024/4095268
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849220827488190464
author Zesong Chen
Chen Yang
Jiang Ji
Miao Chen
Bing Han
author_facet Zesong Chen
Chen Yang
Jiang Ji
Miao Chen
Bing Han
author_sort Zesong Chen
collection DOAJ
description Objectives. To explore the efficacy and the mechanism of the umbilical cord-derived cells combined with cyclosporine A (CsA) in treating aplastic anemia (AA) in mice. Methods. Immune-mediated AA model mice were treated with CsA + UC mesenchymal stem cells (UC-MSC), CsA + umbilical cord blood regulatory T cells (UCB-Treg), UC-MSC, UCB-Treg, CsA alone, or blank control, respectively (n = 9 mice/group). CsA and the cell infusion was administered on d0. Routine peripheral blood testing was performed once weekly; bone marrow colony culture, bone marrow cell flow cytometry, peripheral blood T cell subsets, and serum inflammatory cytokines tests were performed on d14. Transcriptome sequencing was performed for cells from CsA + UC-MSC, CsA + UCB-Treg, and CsA groups to detect the possible related genes. Gene function cluster and signal pathway enrichment analysis were also performed. Results. Blank control mice died due to pancytopenia within 21 days, whereas mice in other groups survived for >28 days. On d14, the CsA + UC-MSC and CsA + UCB-Treg groups had higher white blood cell (WBC) counts than the other groups (p<0.05), along with higher burst-forming unit (BFU) and colony-forming unit-granulocyte, macrophage (CFU-GM) counts (p<0.01). The CsA + UC-MSC group had the highest BFU count (p<0.01). The CsA + UC-MSC and CsA + UCB-Treg groups exhibited the highest bone marrow CD34+ cell proportion (9.68% ± 1.35% and 8.17% ± 0.53%, respectively; p<0.01). Tumor necrosis factor (TNF)-α and interleukin (IL)-2 levels in the CsA + UC-MSC group (p<0.05) and TNF-α, interleukin-2, and interferon (INF)-γ levels in the CsA + UC-Treg group (p<0.01) were lower than those in the CsA group. Compared with CsA treatment, CsA + UC-MSC significantly downregulated the histone methylation pathway (p<0.05), whereas CsA + UCB-Treg significantly upregulated energy metabolism processes (p<0.05). Treatment with CsA + UC-MSC upregulated superoxide dismutase activity compared with CsA + UCB-Treg treatment. Conclusions. Adding UC-MSC or UCB-Treg to CsA markedly enhanced the reconstruction of hematopoiesis in AA mice, with UC-MSC eliciting greater efficiency than UCB-Treg. Accordingly, the addition of these cells could further improve immune abnormalities.
format Article
id doaj-art-4fc4eabed9e849a78cf6ed229b19c7f4
institution Kabale University
issn 1687-9678
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-4fc4eabed9e849a78cf6ed229b19c7f42024-12-02T08:57:55ZengWileyStem Cells International1687-96782024-01-01202410.1155/2024/4095268Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal ModelZesong Chen0Chen Yang1Jiang Ji2Miao Chen3Bing Han4Department of HematologyDepartment of HematologyDepartment of HematologyDepartment of HematologyDepartment of HematologyObjectives. To explore the efficacy and the mechanism of the umbilical cord-derived cells combined with cyclosporine A (CsA) in treating aplastic anemia (AA) in mice. Methods. Immune-mediated AA model mice were treated with CsA + UC mesenchymal stem cells (UC-MSC), CsA + umbilical cord blood regulatory T cells (UCB-Treg), UC-MSC, UCB-Treg, CsA alone, or blank control, respectively (n = 9 mice/group). CsA and the cell infusion was administered on d0. Routine peripheral blood testing was performed once weekly; bone marrow colony culture, bone marrow cell flow cytometry, peripheral blood T cell subsets, and serum inflammatory cytokines tests were performed on d14. Transcriptome sequencing was performed for cells from CsA + UC-MSC, CsA + UCB-Treg, and CsA groups to detect the possible related genes. Gene function cluster and signal pathway enrichment analysis were also performed. Results. Blank control mice died due to pancytopenia within 21 days, whereas mice in other groups survived for >28 days. On d14, the CsA + UC-MSC and CsA + UCB-Treg groups had higher white blood cell (WBC) counts than the other groups (p<0.05), along with higher burst-forming unit (BFU) and colony-forming unit-granulocyte, macrophage (CFU-GM) counts (p<0.01). The CsA + UC-MSC group had the highest BFU count (p<0.01). The CsA + UC-MSC and CsA + UCB-Treg groups exhibited the highest bone marrow CD34+ cell proportion (9.68% ± 1.35% and 8.17% ± 0.53%, respectively; p<0.01). Tumor necrosis factor (TNF)-α and interleukin (IL)-2 levels in the CsA + UC-MSC group (p<0.05) and TNF-α, interleukin-2, and interferon (INF)-γ levels in the CsA + UC-Treg group (p<0.01) were lower than those in the CsA group. Compared with CsA treatment, CsA + UC-MSC significantly downregulated the histone methylation pathway (p<0.05), whereas CsA + UCB-Treg significantly upregulated energy metabolism processes (p<0.05). Treatment with CsA + UC-MSC upregulated superoxide dismutase activity compared with CsA + UCB-Treg treatment. Conclusions. Adding UC-MSC or UCB-Treg to CsA markedly enhanced the reconstruction of hematopoiesis in AA mice, with UC-MSC eliciting greater efficiency than UCB-Treg. Accordingly, the addition of these cells could further improve immune abnormalities.http://dx.doi.org/10.1155/2024/4095268
spellingShingle Zesong Chen
Chen Yang
Jiang Ji
Miao Chen
Bing Han
Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
Stem Cells International
title Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
title_full Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
title_fullStr Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
title_full_unstemmed Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
title_short Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
title_sort umbilical cord blood derived cells can reconstruct hematopoiesis in an aplastic anemia animal model
url http://dx.doi.org/10.1155/2024/4095268
work_keys_str_mv AT zesongchen umbilicalcordbloodderivedcellscanreconstructhematopoiesisinanaplasticanemiaanimalmodel
AT chenyang umbilicalcordbloodderivedcellscanreconstructhematopoiesisinanaplasticanemiaanimalmodel
AT jiangji umbilicalcordbloodderivedcellscanreconstructhematopoiesisinanaplasticanemiaanimalmodel
AT miaochen umbilicalcordbloodderivedcellscanreconstructhematopoiesisinanaplasticanemiaanimalmodel
AT binghan umbilicalcordbloodderivedcellscanreconstructhematopoiesisinanaplasticanemiaanimalmodel